Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo
about
NKT cells stimulated by long fatty acyl chain sulfatides significantly reduce the incidence of type 1 diabetes in nonobese diabetic mice [corrected]The role of NKT cells in tumor immunityTurned on by danger: activation of CD1d-restricted invariant natural killer T cellsThe regulatory role of invariant NKT cells in tumor immunityNKT cell-TCR expression activates conventional T cells in vivo, but is largely dispensable for mature NKT cell biologyMechanisms for Glycolipid Antigen-Driven Cytokine Polarization by V 14i NKT CellsGlycolipids that Elicit IFN-γ-Biased Responses from Natural Killer T CellsStructural and Functional Characterization of a Novel Nonglycosidic Type I NKT Agonist with Immunomodulatory PropertiesEnhanced TCR Footprint by a Novel Glycolipid Increases NKT-Dependent Tumor ProtectionThe differential expression of IL-4 and IL-13 and its impact on type-2 immunityAn in silico approach for modelling T-helper polarizing iNKT cell agonistsHeterogeneity in phenotype and function of CD8+ and CD4/CD8 double-negative Natural Killer T cell subsets in sooty mangabeysToll-like receptor 3 ligand dampens liver inflammation by stimulating Valpha 14 invariant natural killer T cells to negatively regulate gammadeltaT cells.Modulation of NKT cell development by B7-CD28 interaction: an expanding horizon for costimulation.Human natural killer T cells are heterogeneous in their capacity to reprogram their effector functionsPaucity of CD4+ natural killer T (NKT) lymphocytes in sooty mangabeys is associated with lack of NKT cell depletion after SIV infection.Non-classical natural killer T cells modulate plasmid DNA vaccine antigen expression and vaccine-elicited immune responses by MCP-1 secretion after interaction with a beta2-microglobulin-independent CD1d.Critical proinflammatory and anti-inflammatory functions of different subsets of CD1d-restricted natural killer T cells during Trypanosoma cruzi infection.A multifactorial mechanism in the superior antimalarial activity of alpha-C-GalCer.B7-H1-deficiency enhances the potential of tolerogenic dendritic cells by activating CD1d-restricted type II NKT cellsStimulation of natural killer T cells by glycolipidsDefective NKT cell activation by CD1d+ TRAMP prostate tumor cells is corrected by interleukin-12 with α-galactosylceramide.The T-Cell Response to Lipid Antigens of Mycobacterium tuberculosisIntrinsic TGF-β signaling promotes age-dependent CD8+ T cell polyfunctionality attrition.Reciprocal Crosstalk between Dendritic Cells and Natural Killer T Cells: Mechanisms and Therapeutic Potential.Mechanisms of innate lymphoid cell and natural killer T cell activation during mucosal inflammation.Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion.Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides.Glycolipid antigen induces long-term natural killer T cell anergy in mice.Cytokine dependent and independent iNKT cell activationThe ROS scavenger, NAC, regulates hepatic Vα14iNKT cells signaling during Fas mAb-dependent fulminant liver failure.The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells.NKT cell stimulation with glycolipid antigen in vivo: costimulation-dependent expansion, Bim-dependent contraction, and hyporesponsiveness to further antigenic challenge.Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy.Gestation stage-dependent mechanisms of invariant natural killer T cell-mediated pregnancy lossiNKT cell autoreactivity: what is 'self' and how is it recognized?Rapid development of a gamma interferon-secreting glycolipid/CD1d-specific Valpha14+ NK1.1- T-cell subset after bacterial infection.Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infectionTargeting NKT cells and PD-L1 pathway results in augmented anti-tumor responses in a melanoma modelDivergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity.
P2860
Q21134826-9449EC59-5826-497A-8A94-81D2F9A623C2Q24648939-6003BA31-CE42-4327-A678-2DD4EE3E0CADQ26825059-F4994993-F05A-4183-8D74-2F2EC02A07A1Q27023425-F350D22D-AD0C-4365-A2ED-7C57BB85E1C7Q27317219-968F7A20-A6F1-4352-8893-6B91DB6EF714Q27658388-A85EE192-F8DD-4B25-A414-1C62E8EFFB15Q27676395-F2E68A05-8868-4077-848B-4B07202A060DQ27677017-E75237E6-9498-4657-A86D-3F30F829E996Q27679771-075D3642-E71E-4AD3-9CFB-91D398583E13Q28083968-65804180-8F1D-4E21-8362-A5BEBBDDE829Q28539366-C9C5BAF6-8FAA-418B-9AD6-C52106728996Q29396370-8949D512-3127-4EED-A819-1B9CD0372C5EQ30432794-BF1BAE96-6141-4827-85AB-BC196435056FQ30845162-0A9171B6-7C30-4C37-B4A9-10CEAB6D43EFQ33267309-BF7F855E-D5A5-4206-BE6D-48BB967114F0Q33547424-7D75E03D-A67C-4474-8B97-83AF65406084Q33553298-87E6279E-BC76-49AD-8E4D-8A535A656D16Q33558006-43BC2FBC-67CA-40B9-801C-E0D1E66E2FA7Q33570532-BED33FEC-4FCA-4D4C-86B6-703B32FD8400Q33592911-CBA1084D-8AC0-47F9-AF60-CCAE2DF6DFADQ33599059-8E96C9DD-2216-4223-91A8-83A5668F8ADFQ33622444-CA2D4CC9-5D21-406F-8F88-530C66BB2AADQ33658959-0A2C5D3A-AEA3-4074-A3D2-20BF9A2EA515Q33685895-D238CBBD-9EB3-4839-8211-EE7800504DA8Q33720359-13214038-EB9E-466D-8D2B-05660660C7E3Q33758636-F8950C58-8E63-4A13-A969-DB28D1B1B1CAQ33762686-17553EE7-3BCF-4E3E-A5F8-599DF25BB2BEQ33927443-B553B35C-BD93-4FC0-B643-339E61581431Q33930869-9F9FDCB0-A29C-493C-9D45-042DA4D613E0Q34039891-71A0ED12-098B-4BE9-9660-F914F8BFF361Q34305284-9FA32028-837B-4A2D-9021-BB82D90FF220Q34328138-1E7F2C28-BA26-4251-8B48-F3A6F5FD0F54Q34333607-812EC250-E067-4919-9002-FD3E238B65E8Q34431441-C5D2F863-6CA7-44AF-844A-2ECB12AB8848Q34574847-673D3C51-EBA6-4F2C-8F89-F1BE3A9C7C9CQ34760309-C7C03E76-7BD4-40FE-A379-2B4ADF8B4872Q35073920-83671D54-B7EE-4CA7-B8AA-B3FBCC06C018Q35213598-FEEF9CBB-CA74-4619-8A53-39F4440A81A9Q35516545-8958E5B1-F1A2-4E7B-AECE-16BCB6CEBD4CQ35624378-91279113-2A96-4401-BED0-B71734954485
P2860
Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo
@ast
Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo
@en
type
label
Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo
@ast
Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo
@en
prefLabel
Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo
@ast
Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo
@en
P2093
P2860
P356
P1476
Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo
@en
P2093
Daniel B Stetson
Jennifer L Matsuda
Jody L Baron
Markus Mohrs
Richard M Locksley
Stéphane Sidobre
P2860
P304
P356
10.1073/PNAS.1332805100
P407
P577
2003-06-26T00:00:00Z